Developing and Strengthening Cannabis Warnings: Warning Message Testing
調査の概要
状態
詳細な説明
The purpose of this activity is to identify promising cannabis warning messages from different themes.
Setting: An online survey of adults who live in the United States.
Participants: An estimated N=1500 adults who live in the United States, including both people who use cannabis and those who do not use cannabis. Participants will be recruited by Qualtrics Services. Participants who are eligible for the study will view a consent form as part of the survey and check a box to indicate that they agree to participate in the study. Once the participant has completed consent, they will be able to begin the survey.
Procedures: Participants will complete a within-subjects experiment in which they view and rate cannabis warning messages from different themes. Participants will be screened for inclusion and answer questions on demographic information and susceptibility to cannabis use. Participants will then be randomly assigned to view 7 cannabis warning messages from different themes developed as part of previous study activities. After viewing each cannabis warning message, participants will rate the message on awareness, clarity, believability, cognitive elaboration, perceived message effectiveness, and reactance. There will be a total of 11 warning themes plus control. After viewing and rating their assigned cannabis warning messages, participants will answer additional questions about cannabis risk perceptions and use behavior (if applicable), additional demographic information, and about their use of tobacco and alcohol. The survey will take 15-20 minutes.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Sarah D Kowitt, PhD, MPH
- 電話番号：919-974-4980
- メール：kowitt@unc.edu
研究場所
-
-
North Carolina
-
Chapel Hill、North Carolina、アメリカ、27514
- University of North Carolina at Chapel Hill
-
コンタクト：
- Sarah D Kowitt, PhD, MPH
- 電話番号：919-974-4980
- メール：kowitt@unc.edu
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Age 18 years of age and older
- Live in the United States
Exclusion Criteria:
- Age less than 18 years of age
- Does not live in the United States
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Cannabis warning messages
Participants will view and rate 7 cannabis warning messages. The cannabis warning messages cover 11 different themes plus a control theme and were identified in a previous study activity. Theme 1: Constituents Theme 2: Cognitive Functioning Theme 3: Cardiovascular Health Theme 4: Motor Vehicle Crashes Theme 5: Dependence Theme 6: Psychosis and Schizophrenia Theme 7: Mental Health Theme 8: Reproductive Health Theme 9: Respiratory Health Theme 10: Edibles Theme 11: Cannabis Hyperemesis Syndrome Theme 12: Control |
Participants will view and rate a message about constituents.
Participants will view and rate a message about cognitive functioning.
Participants will view and rate a message about cardiovascular health.
Participants will view and rate a message about motor vehicle crashes.
Participants will view and rate a message about dependence.
Participants will view and rate a message about psychosis and schizophrenia.
Participants will view and rate a message about mental health.
Participants will view and rate a message about reproductive health.
Participants will view and rate a message about respiratory health.
Participants will view and rate a message about edibles.
Participants will view and rate a message about cannabis hyperemesis syndrome.
Participants will view and rate a control message.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Cognitive Elaboration
時間枠：Baseline (one time online survey)
|
A one item measure of cognitive elaboration to assess how much a message makes the participant think about the health risks of cannabis.
Response options are on a 5-point scale from 5='A great deal' to 1= 'Not at all', with higher scores indicating higher cognitive elaboration.
|
Baseline (one time online survey)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Perceived Message Effectiveness
時間枠：Baseline (one time online survey)
|
This survey item assesses perceived message effectiveness in terms of how concerned the message makes the participant feel about the health effects of using cannabis.
Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher perceived message effectiveness.
|
Baseline (one time online survey)
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Clarity
時間枠：Baseline (one time online survey)
|
This survey item assesses the extent to which a participant feels that the message is clear.
Response options are on a 5-point scale from 5='Very clear' to 1='Not clear at all' with higher scores indicating that a message is more clear.
|
Baseline (one time online survey)
|
|
Believability
時間枠：Baseline (one time online survey)
|
This survey item assesses the extent to which a participant feels that the message is believable.
Response options are on a 5-point scale from 5='Very believable' to 1='Not at all believable' with higher scores indicating that a message is more believable.
|
Baseline (one time online survey)
|
|
Reactance
時間枠：Baseline (one time online survey)
|
This survey item assesses reactance in terms of how much a participant is annoyed by the message.
Response options are on a 5-point scale from 5='A great deal' to 1='Not at all' with higher scores indicating higher reactance to the message.
|
Baseline (one time online survey)
|
協力者と研究者
捜査官
- 主任研究者：Sarah D Kowitt, PhD, MPH、University of North Carolina, Chapel Hill
- 主任研究者：Leah M Ranney, PhD, MA、University of North Carolina, Chapel Hill
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 24-1616
- R01DA058003 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。